1. Ahman DL, Bisel HF, Hahn RG (1974) Phase II clinical trial of isophosphamide (NSC-109724) in patients with advanced breast cancer. Cancer Chemother Rep 58: 861
2. Becher R, Höfeler H, Kloke O, Kurschel E, Schilcher RB, Weinhardt O, Schmidt CG (1989) Ifosfamide, methotrexate, and 5-fluorouracil in advanced pretreated breast cancer. Semin Oncol 16: 59
3. Belpomme D, Gisselbrecht C, Marty M, Cour V, Hertier F, Le Rol A, Mignot L, Maral J (1987) Long duration of response induced by vindesine, mitoxantrone and mitomycin C in metastatic breast carcinoma. Proc ASCO 23: 224
4. Brade WP, Seeber S, Herdrich K (1985) Experimental and clinical comparative activity of ifosfamide and cyclophosphamide. In: Recent experience with ifosfamide/mesna in solid tumors. Proc ECCO 3: 5
5. Bramwell VH, Mouridsen HT, Santoro A, Blackledge G, Somers R, Verwey J, Dombernowsky P, Onsrud M, Thomas D, Sylvester R, Van Oosterom A (1987) Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas. Eur J Cancer Clin Oncol 23: 311